1
项与 CLL-1,CD33,CD38 and/or CD123-specific universal CAR-T cells(Shenzhen Geno-Immune Medical Institute) 相关的临床试验Universal CAR T Cells for the Treatment of Acute Myeloid Leukemia
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T-cell products targeting CLL-1, CD33, CD38 and CD123 in patients with relapsed and refractory AML. The study also aims to learn more about the function of the universal CAR T cells and their persistency in AML patients.
100 项与 CLL-1,CD33,CD38 and/or CD123-specific universal CAR-T cells(Shenzhen Geno-Immune Medical Institute) 相关的临床结果
100 项与 CLL-1,CD33,CD38 and/or CD123-specific universal CAR-T cells(Shenzhen Geno-Immune Medical Institute) 相关的转化医学
100 项与 CLL-1,CD33,CD38 and/or CD123-specific universal CAR-T cells(Shenzhen Geno-Immune Medical Institute) 相关的专利(医药)
100 项与 CLL-1,CD33,CD38 and/or CD123-specific universal CAR-T cells(Shenzhen Geno-Immune Medical Institute) 相关的药物交易